A relatively unimportant drug Fujifilm’s medical systems arm developed years ago that wasn’t expected to do anything for the company’s bottom line any time soon seems to help coronavirus patients recover. Shares of the Japanese company’s stock surged 15 percent on the news on March 18, news outlets reported, including Reuters. The antiviral drug, Avigan,
